Table 2 Outcome measures, headache phenotype and ictal cutaneous allodynia at baseline
From: Intracranial pressure directly predicts headache morbidity in idiopathic intracranial hypertension
Headache at baseline, n (%) | 63 (95%) |
Headache severity, verbal rating scale (0–10), mean (SD) | 5.0 (2.0) |
Headache duration (hours), mean (SD) | 8.2 (6.3) |
Headache frequency (days per month), mean (SD) | 22.2 (7.8) |
Analgesic use (days per month), mean (SD) | 12.3 (9.0) |
HIT-6 score, mean (SD) | 65 (7.3) |
SF-36, physical component score, mean (SD) n = 60 | 28.7 (12.7) |
SF-36, mental component score, mean (SD) n = 60 | 37.7 (11.0) |
Headache phenotypes (not mutually exclusive), n (%) | n = 66 |
No headache | 1 (2%) |
Migraine-like | 57 (86%) |
Migraine-like without aura | 34 (60%) |
Migraine-like with aura | 23 (40%) |
Chronic migraine-like | 40 (70%) |
Episodic migraine-like | 17 (30%) |
Headache attributed to IIH | 44 (67%) |
Medication-overuse | 23 (35%) |
Tension-like | 1 (2%) |
Cutaneous allodynia (ictal), mean (SD), n = 58 | 19.16 (5.79) |
None (0–2) | 0 (0%) |
Mild (3–5) | 0 (0%) |
Moderate (6–8) | 2 (3.4%) |
Severe (9+) | 56 (96.6%) |